Esomeprazole Magnesium
Product Images NDC 50090-4639

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 50090-4639). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure of esomeprazole magnesium trihydrate, showing the molecular arrangement of its components including the magnesium ion and associated water molecules.*

FDA Label Image

Figure 2 Maintenance Of Healing Rates By Month (study 117) (Image 02)

Line graph titled 'Maintenance of Healing Rates by Month (Study 177)' showing percent healing maintained over six months for esomeprazole magnesium delayed-release capsules at 40 mg, 20 mg, and 10 mg doses, compared with placebo. The y-axis shows percent maintained (0 to 100%), and the x-axis shows months (0 to 6). Higher doses maintain higher healing rates over time, with placebo showing the lowest rates.*

FDA Label Image

Figure 3 Maintenance Of Healing Rates By Month (study 178) (Image 03)

A line graph titled 'Maintenance of Healing Rates by Month (Study 178)' showing percent healing maintained over 6 months. It compares Esomeprazole Magnesium delayed-release capsules at 40 mg, 20 mg, and 10 mg doses versus placebo. The Y-axis represents percent maintained, and the X-axis shows months from 0 to 6. Higher doses maintain healing rates closer to 100%, while lower doses and placebo show decline over time.*

FDA Label Image

Figure 4 Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Image 04)

A line graph titled 'Percent of Patients Symptom-Free of Heartburn by Day (Study 225)' showing the percentage of patients symptom-free on the y-axis and diary day on the x-axis from 0 to 28 days. It compares Esomeprazole Magnesium Delayed-release Capsules at 40 mg and 20 mg doses with placebo. The graph shows increasing symptom-free percentages over time for both dosages, higher than placebo throughout the study period.*

FDA Label Image

Figure 5 Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Image 05)

A line graph titled 'Percent of Patients Symptom-Free of Heartburn by Day (Study 226)' comparing three groups over 28 days: Esomeprazole Magnesium Delayed-release Capsules 40 mg, 20 mg, and placebo. The y-axis represents the percent of patients symptom-free, and the x-axis shows diary days. The graph shows higher symptom-free percentages for both dosages of esomeprazole compared to placebo over time.*

FDA Label Image

Label Image (Lbl500904639)

The packaging label for Esomeprazole magnesium delayed-release capsules, each containing 40 mg of active ingredient. The label includes storage instructions to keep at 77 degrees Fahrenheit, mentions 30 delayed-release capsules in the package, and provides the Labeler as A-S Medication Solutions. The label also displays the NDC number 50090-4639-0 and additional batch and packaging information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.